Business
Brailer firm invests in e-prescribing
NEWS IN BRIEF — Posted May 19, 2008
David Brailer, MD, PhD, former national coordinator for health information technology, has entered the e-prescribing market after his investment firm, Health Evolution Partners, invested in the e-prescribing company Prematics.
The investment in Prematics, based in Bethesda, Md., is Health Evolution Partners' first since its founding. The amount was not disclosed.
Dr. Brailer founded Health Evolution Partners after resigning from his appointed post of national coordinator in 2006. He said entering the e-prescribing market was a major objective of his venture fund, and Prematics seemed to be the best choice. He will serve on the company's board of directors.
Kevin Hutchinson, former president and founder of the e-prescribing company SureScripts, is president and CEO of Prematics, which calls its e-prescribing system ScriptTone.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2008/05/19/bibf0519.htm.












